We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-3.85%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$140B
AUM Growth
+$5.37B
Cap. Flow
+$13.5B
Cap. Flow %
9.64%
Top 10 Hldgs %
30.28%
Holding
6,714
New
321
Increased
2,151
Reduced
2,607
Closed
759

Sector Composition

Rank Sector Weight
1 Technology 8.94%
2 Healthcare 5.53%
3 Financials 5.03%
4 Consumer Discretionary 4.6%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEAV icon
5326
Weave Communications
WEAV
$548M
$2K ﹤0.01%
475
-7,551
-94% -$38.6K
WEYS icon
5327
Weyco Group
WEYS
$374M
$2K ﹤0.01%
95
-275
-74% -$7.01K
XNET
5328
Xunlei
XNET
$334M
$2K ﹤0.01%
+1,454
New +$2.3K
BNT
5329
Brookfield Wealth Solutions
BNT
$11.8B
$2K ﹤0.01%
78
-300
-79% -$9.62K
ASBPW
5330
CALL
Aspire Biopharma Warrant
ASBPW
$579K
$2K ﹤0.01%
13,950
SBT
5331
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$2K ﹤0.01%
261
-816
-76% -$4.84K
VIRX
5332
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2K ﹤0.01%
551
-495
-47% -$2.1K
TGAAW
5333
CALL
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
$2K ﹤0.01%
33,334
CDAQW
5334
CALL
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$2K ﹤0.01%
19,920
BGXX
5335
DELISTED
Bright Green Corporation Common Stock
BGXX
$2K ﹤0.01%
1,987
-527
-21% -$815
HEWG
5336
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$2K ﹤0.01%
93
FREE
5337
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$2K ﹤0.01%
615
-2,591
-81% -$14.1K
TARO
5338
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2K ﹤0.01%
63
ADTH
5339
DELISTED
AdTheorent Holding Co
ADTH
$2K ﹤0.01%
1,080
-333
-24% -$891
TGAN
5340
DELISTED
Transphorm, Inc. Common Stock
TGAN
$2K ﹤0.01%
346
-945
-73% -$4.65K
QDROW
5341
CALL
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$2K ﹤0.01%
33,334
CMLS
5342
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$2K ﹤0.01%
272
-889
-77% -$7.55K
VIEW
5343
DELISTED
View, Inc. Class A Common Stock
VIEW
$2K ﹤0.01%
28
-106
-79% -$12K
SNCE
5344
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$2K ﹤0.01%
64
-130
-67% -$4.82K
GRCL
5345
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$2K ﹤0.01%
718
-2,371
-77% -$7.71K
MARK
5346
DELISTED
Remark Holdings, Inc.
MARK
$2K ﹤0.01%
799
-3,068
-79% -$12.4K
LMDXW
5347
CALL
DELISTED
LumiraDx Limited Warrant
LMDXW
$2K ﹤0.01%
20,058
NETI
5348
DELISTED
Eneti Inc.
NETI
$2K ﹤0.01%
357
-584,374
-100% -$4.15M
IMPL
5349
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$2K ﹤0.01%
345
-60
-15% -$459
PRPC.WS
5350
CALL
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$2K ﹤0.01%
9,197

Similar funds

Citigroup's Q3 2022 Portfolio in Review

As of Q3 2022, Citigroup held 6,714 positions worth $140B, up 4% from $134B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citigroup deployed $13.5B of net new capital in Q3 2022, opening 321 new positions and adding to 2,151 existing holdings. Its largest new stake was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.31B trimmed.

  • Citigroup's largest Q3 2022 buy was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
  • Citigroup added most to Lowe's Companies in Q3 2022, an estimated $539M increase.
  • Citigroup's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.31B.
  • Citigroup fully exited GCP Applied Technologies Inc. in Q3 2022, selling an estimated $18.7M.
  • Citigroup's ten largest holdings make up 30% of its $140B portfolio in Q3 2022.
  • Citigroup opened 321 new positions and closed 759 in Q3 2022.
  • Citigroup's portfolio value rose 4% quarter-over-quarter to $140B.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.